Tim Sparey 

27 years of experience of working in blue chip big pharma, specialty pharma and biotech, including CEO and board level positions

Extensive experience in advising on pharma licensing and M&A deals – 22 deals with cumulative value >$1.8b

CEO at In4Derm, previously CEO at Novintum Bioscience, OpsiRx and Q Chip and CBO at Proximagen

15 years at Merck as Research Fellow and then Licensing Director in Global BD&L

PhD in Chemistry from University of Warwick